Scrip
GSK settles Avandia lawsuits ahead of Philadelphia trial
04 June 2010
Peter Mansell
Please Login to read the full article.
04 June 2010
Peter Mansell
GlaxoSmithKline has settled the first case scheduled for trial in the US over claims that the company's diabetes drug Avandia (rosiglitazone) increases the risks of heart attack or other ischaemic cardiovascular events. The trial was due to start in a Philadelphia court on 1 June.
The company...
Please Login to read the full article.
RELATED CONTENT
NEWS
- GSK's $750 million settlement on former Paxil plant followed little-known Justice probe
- AstraZeneca finalises $520 million settlement in Seroquel off-label probe
- Court dismisses Texas suit seeking to recover Medicaid-related Vioxx expenses
- AstraZeneca to pay $520 million in US Seroquel off-label probe
COMMENT
Other Informa Comment
FEATURES
- Connexios: Harnessing the Indian cost advantage in network biology
- GE Healthcare aims to end unpredictability in early drug research
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
